Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy

Ten subjects received 600 to 1,200 mg of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor ritonavir per day. Following 2 weeks of therapy, plasma HIV RNA levels decreased by a mean of 1.57 (range, 0.89 to 1.96) log units. With continued therapy, HIV RNA levels began to rise in eigh...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Eastman, P. Scott, Mittler, John, Kelso, Reed, Gee, Chris, Boyer, Eric, Kolberg, Janice, Urdea, Mickey, Leonard, John M., Norbeck, Daniel W., Mo, Hongmei, Markowitz, Martin
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1998
Matèries:	Animal Viruses
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC110088/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9573287/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.72.6.5154-5164.1998
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!